The AI doctor experiments
AI adoption is speeding ahead in healthcare, and those at the bleeding edge think we’re getting closer to AI acting autonomously – without a doctor in the loop. Early experiments are underway: Utah is letting AI write and renew prescriptions. An HHS program wants to build AI agents with FDA approval. What are the goals of early pilot programs, and how will the learnings inform where autonomous AI goes from here?
In conversation with OpenAI’s Nate Gross
OpenAI has big plans in healthcare. We’ll sit down with head of health Nate Gross to talk about the company’s products, ambitions and competition.
The health record floodgates are open — now what?
After years of regulatory and logistical efforts, patients are finally able to easily access their own health and medical records. AI and health tech companies are jumping at the opportunity, and asking customers to connect their data for more personalized care. But is the access enough to really improve outcomes?
What health tech investments will pay off?
New tech and new access to data are supercharging health tech tools that companies say will help improve care and cut down on costs. But what separates the good from the great, and what should founders target to actually make a difference? We'll sit down with two investors and hear their philosophies.
6:30pm - 6:45pm ET
Employers as the target
About half the US population gets health coverage through an employer. How can employers deploy digital and AI-powered tools that provide real care benefits – without contributing to higher costs?
Dan Mendelson
CEO, Morgan Health, a JPMorganChase business unit
Sponsored by
6:45pm - 7:00pm ET
Direct to consumer
Patients have increasing agency over their own health information and health care. Can going directly to them actually close care gaps?
Vig Chandramouli
Partner, Oak
